Adaptive Phage Therapeutics, a TEDCO portfolio company, update: FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections
Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an
Light Point Security, TEDCO Portfolio Company, acquired by McAfee to Extend MVISION Unified Cloud Edge (UCE) Capabilities for Secure Access Service Edge (SASE)
McAfee, the device-to-cloud cybersecurity company, today announced it has entered into a definitive